Greenlight Biosciences Holdings Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Greenlight Biosciences regular Real Value cannot be determined due to lack of data. The prevalent price of Greenlight Biosciences is $0.0. Our model calculates the value of Greenlight Biosciences from evaluating the firm fundamentals such as Return On Asset of -0.82, shares outstanding of 151.68 M, and Return On Equity of -3.67 as well as inspecting its technical indicators and probability of bankruptcy.
Greenlight Biosciences Total Value Analysis
Greenlight Biosciences Holdings is currently estimated to have valuation of 90.5 M with market capitalization of 45.43 M, debt of 80.48 M, and cash on hands of 44.13 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Greenlight Biosciences fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
90.5 M | 45.43 M | 80.48 M | 44.13 M |
Greenlight Biosciences Investor Information
About 43.0% of the company shares are held by company insiders. The book value of Greenlight Biosciences was currently reported as 0.14. The company recorded a loss per share of 1.12. Greenlight Biosciences had not issued any dividends in recent years. Based on the key indicators related to Greenlight Biosciences' liquidity, profitability, solvency, and operating efficiency, Greenlight Biosciences Holdings is not in a good financial situation at the moment. It has a very high risk of going through financial straits in March.Greenlight Biosciences Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Greenlight Biosciences has an asset utilization ratio of 4.3 percent. This suggests that the Company is making $0.043 for each dollar of assets. An increasing asset utilization means that Greenlight Biosciences Holdings is more efficient with each dollar of assets it utilizes for everyday operations.Greenlight Biosciences Ownership Allocation
Greenlight Biosciences Holdings has a total of 151.68 Million outstanding shares. Greenlight Biosciences secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Greenlight Biosciences Profitability Analysis
The company reported the previous year's revenue of 6.38 M. Net Loss for the year was (167.06 M) with loss before overhead, payroll, taxes, and interest of (87.22 M).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Greenlight Biosciences' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Greenlight Biosciences and how it compares across the competition.
Greenlight Biosciences Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 132 M |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Consideration for investing in Greenlight Stock
If you are still planning to invest in Greenlight Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Greenlight Biosciences' history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |